MGNX · Macrogenics Inc
United States · RS rating 38 · As of 2026-10-14
| Price | 3.31 USD |
|---|---|
| 1-day change | -3.2% |
| RS rating (overall / 1M / 3M / 12M) | 38 / 13 / 20 / 95 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 29 / 34 / 39 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +153.4% |
| Sales growth Q/Q | -43.4% |
| Distance from 52-week high | +31.9% |
| Market cap (USD) | $202.1M |